Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Keep Those #ACEP18 Tweets Coming

By Jeremy Samuel Faust, MD, MS, MA, FACEP | on October 3, 2018 | 0 Comment
ACEP18 The Feed
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Someone asked me yesterday if I had noticed a change in how people use Twitter at ACEP’s Scientific Assembly over the years. In a word: yes. So much has changed and grown. In fact, I still remember the first ad hoc in-person meet-up of Twitter users back at ACEP13 in Seattle, Washington. There were literally fewer than 10 of us sitting around a table having breakfast, trying to figure out how we could convince people in emergency medicine that social media was even worthwhile. We were confident that social media use in medicine and medical education would grow but we had no inkling that five years later, it would be so central to the conference-going experience of ACEP’s membership.

You Might Also Like
  • ACEP18 Research Forum’s Electronic Showcase Integrates Science, Education Throughout Conference
  • #ACEP18 Hashtag Offers Clinical Pearls, Insight, and Meeting News
  • Tweets are Flying at #ACEP15
Explore This Issue
ACEP News: Vol 28 – No 02 – February 2009, ACEP18 Wednesday Daily News

One of the most welcome developments has been the increasing interactivity of social media. Social media that is actually social? What a concept! A few years ago, it was actually not uncommon for multiple people to live-tweet the same lecture, in much the same ways. It was as if we were all living in parallel universes and not really interacting. These days, however, experienced tweeps know that if one person is live-tweeting a lecture, the rest of us don’t have to. We can chime in with comments, questions, and ideas.

Dr. Liam Yore (@movinmeat, still one of the greatest twitter handles ever), tweeted out “Hey #ACEP18 Twitter. Here’s a fun game. Tweet the name of a drug shortage you’ve had to grapple with in the last month. I’ll start: Fluorescein.” Dr. Howie Mell (@DrHowieMell) responded, “Diltiazem IV, ondansetron IV, dilaudid IV (nubain, and morphine too) and, most recently, injectable diazepam.” Dr. Ilene Benator (@irb123) added “Valium IM, reglan, compazine, hydralazine. Morphine.” I personally responded to Dr. Benator, adding, “Sadly, I find it difficult to do the Goldfrank’s Toxicology valium-based approach to alcohol withdrawal without, you know, actual valium available!” Dr. Dink Jardine (@dinkjardine) tweeted, “Sumatriptan, lidocaine, ofloxicin. Not [at] #ACEP18 but was feeling left out of the cool kids table,” again proving that you don’t need to be here in person to get in on the action.

This thread ended up being disconcertingly long, precisely because the problem of drug shortages has become so rampant here in the United States. But Judd Hollander
(@JuddHollander) won the mic-drop prize for cleverness with a simple reply. The critical shortage he has noticed? “Turkey (as in sandwich).” I had to ask Dr. Hollander if they put his hospital on diversion when they run out of those. So far, no reply.

Pages: 1 2 | Single Page

Topics: ACEPACEP18American College of Emergency PhysiciansFeedTwitter

Related

  • VACEP Legal Victory Illustrates Why the Prudent Layperson Standard Still Matters

    October 26, 2023 - 1 Comment
  • “If Not Me, Then Who?”

    March 16, 2022 - 4 Comments
  • ACEP’s New Executive Director to Start in July

    June 16, 2020 - 0 Comment

Current Issue

ACEP Now: June 2025 (Digital)

Read More

About the Author

Jeremy Samuel Faust, MD, MS, MA, FACEP

Jeremy Samuel Faust, MD, MS, MA, FACEP, is Medical Editor in Chief of ACEP Now, an instructor at Harvard Medical School and an attending physician in department of emergency medicine at Brigham & Women’s Hospital in Boston. Follow him on twitter @JeremyFaust.

View this author's posts »

No Responses to “Keep Those #ACEP18 Tweets Coming”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603